The Cooper Companies, Inc. The Cooper Companies, Inc.

The Cooper Companies, Inc.

COO

Rang in Aktien #1884
The Cooper Companies, Inc. (COO) operates as a global medical device firm,... The Cooper Companies, Inc. (COO) operates as a global medical device firm, primarily focused on developing, producing, and distributing products through two distinct business units: CooperVision and CooperSurgical. CooperVision specializes in contact lenses. Their product range includes spherical lenses for common vision issues like nearsightedness and farsightedness, as well as advanced lenses such as toric for astigmatism, multifocal for presbyopia, and specialized options addressing myopia, dry eyes, and eye fatigue. These vision correction solutions are available across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Meanwhile, CooperSurgical is dedicated to women's and family health, providing a wide array of medical devices, fertility treatments, genetic testing, diagnostic tools, and contraceptives to healthcare providers and patients globally. This segment's offerings encompass various surgical and office-based products like PARAGARD (an IUD), uterine manipulators, retractors, and closure devices. It also delivers comprehensive fertility services, including specialized consumables, equipment, embryo services, and preimplantation genetic screening. Established in 1958, The Cooper Companies, Inc. is headquartered in San Ramon, California.
Aktienkurs
$59.03
Zuletzt synchronisiert: 2026-10-20
Marktkapitalisierung
$11.23B
Veränderung (1 Tag)
1.50%
Veränderung (1 Jahr)
-21.29%
Land
US
Handel The Cooper Companies, Inc. (COO)

Kategorie

Healthcare
Umsatz von The Cooper Companies, Inc. (COO)
Umsatz im Jul 2026 TTM: $4.24B
Laut den aktuellen Finanzberichten von The Cooper Companies, Inc. beträgt der derzeitige Umsatz des Unternehmens (TTM) $4.24B. Im Jahr 2024 erzielte das Unternehmen einen Umsatz von $3.90B eine Steigerung gegenüber dem Umsatz im Jahr 2023, der $3.59B betrug. Der Umsatz ist der Gesamtbetrag, den ein Unternehmen durch den Verkauf von Waren oder Dienstleistungen erzielt. Im Gegensatz zum Gewinn werden keine Ausgaben abgezogen.
Umsatzverlauf für The Cooper Companies, Inc. von 2000 bis 2026
Umsatz am Ende jedes Jahres
Jahr Umsatz ändert
2026 (TTM) $4.24B 3.53%
2025 $4.09B 5.06%
2024 $3.90B 8.41%
2023 $3.59B 8.61%
2022 $3.31B 13.20%
2021 $2.92B 20.22%
2020 $2.43B -8.39%
2019 $2.65B 4.76%
2018 $2.53B 18.41%
2017 $2.14B 8.75%
2016 $1.97B 9.45%
2015 $1.80B 4.62%
2014 $1.72B 8.19%
2013 $1.59B 9.87%
2012 $1.45B 8.59%
2011 $1.33B 14.87%
2010 $1.16B 7.23%
2009 $1.08B 1.62%
2008 $1.06B 11.84%
2007 $950.64M 10.67%
2006 $858.96M 6.49%
2005 $806.62M 64.56%
2004 $490.18M 19.04%
2003 $411.79M 30.60%
2002 $315.31M 34.42%
2001 $234.57M 18.88%
2000 $197.32M 0.00%
Umsatz vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Umsatz Umsatzunterschied Land
$11.03B 160.43%
US
$34.74B 719.84%
FR
- -
JP
$20.84B 391.83%
US
- -
CH